Add this topic to your myFT Digest for news straight to your inbox
With almost 800 trials under way observers warn scientific rigour is being compromised
US reforms, Lucica Ditiu on TB, the healthiest countries
Project will examine links between genes, biochemistry, health and lifestyle
Analysts predict first medicine for skin illness will make $6bn in annual sales
French drugmaker faces questions over how to offset declining Lantus revenues
Judge says Praluent infringes on patents held by Amgen covering rival treatment
US stocks make little progress at start of the week
Consumer groups, carmakers and transport sector make gains
Stocks helped by report showing US factory sector had expanded
Healthcare and financials are the two big sectors that end the period in the red
Poorer areas not feeling benefit of growing economy and job creation
Companies recently approved for new cholesterol drugs climb
Pharmacy group secures big discount on medicine’s $14,000-a-year price tag
New multibillion-dollar drugs offset patent expiries
Technology-heavy index powered by Yellen comments on plan to raise rates slowly
Breakthrough cholesterol-lowering medicines could add $150bn to US health bill
As big pharma bets huge sums on the next breakthrough drugs, some investors fear another bubble
Advances in innovation help sector add to 2014 gains, bucking wider January sell-off
The Nasdaq biotech index is on the rise again
US equity markets waver following Monday holiday
International Edition